Dana Farber/Brigham and Women's Cancer Center combines the expertise of two world-renowned centers focused on the treatment of all forms of lung cancer, including a highly specialized program for mesothelioma.
The International Mesothelioma Program (IMP), located at Brigham and Women's Hospital, is one of the largest programs of its kind in the world. Approximately 2,000 new patients are diagnosed with mesothelioma every year in the United States, and our center treats more than 300 patients annually. Our ultimate mission is to offer state-of-the-art treatment to patients with mesothelioma, and to continuously innovate new options for the care of patients with this disease.
Exceptional Care for Patients with Mesothelioma
DF/BWCC is home to the International Mesothelioma Program, and to several of the world's most highly renowned experts in mesothelioma.
We treat more people with mesothelioma than any other program in the world.
We offer a multidisciplinary team approach to care based on each patient's unique situation.
We have deep expertise in diagnosing even the most complicated cases.
We provide access to the very latest therapies, including clinical trials.
Our specialists offer a range of tools for symptom management to help you feel better.
Our dedicated mesothelioma support team provides counseling, emotional and spiritual support, as well as practical help with housing and financial needs.
We offer our patients the full expertise of two world-class medical centers — Brigham and Women's Hospital and Dana-Farber Cancer Institute.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: